|
|
Post by jckrdu on Jan 20, 2015 21:18:34 GMT
A good day. Closed up 10% right at the high of day at $2.07.... on more than twice the average volume.
Nice steady buying and climb today... looked like institutional buying IMO.
Looking for more gains in the days/weeks ahead to confirm the breakout.
|
|
|
|
Post by Yelk on Jan 20, 2015 21:34:50 GMT
It was red this morning for 5-10 min and I was going to buy another chunk. Can bet I regretted it eh  . Oh well the game we play. Interesting times ahead of us. |
|
|
|
Post by RLC on Jan 21, 2015 14:14:30 GMT
Looking good in pre market trading. At $2.11 with the bid/ask at 2.11/2.18
|
|
|
|
Post by jckrdu on Jan 21, 2015 14:46:51 GMT
Looking good in pre market trading. At $2.11 with the bid/ask at 2.11/2.18 Nice volume in the first 10-15 minutes of trading. Very small gap between $2.07 and $2.09. It's pulled back and tried to fill it a couple of times, and did partially fill it as the gap was larger earlier. It may try to fill that gap again before moving up. |
|
|
|
Post by Yelk on Jan 21, 2015 14:50:38 GMT
Oops I see red, hmm to buy or not.
|
|
|
|
Post by lovie350z on Jan 21, 2015 15:10:39 GMT
Thinking the same thing Yelk
|
|
|
|
Post by Yelk on Jan 21, 2015 15:15:14 GMT
Yup here it comes back
|
|
|
|
Post by jckrdu on Jan 21, 2015 15:16:35 GMT
Looking good in pre market trading. At $2.11 with the bid/ask at 2.11/2.18 Nice volume in the first 10-15 minutes of trading. Very small gap between $2.07 and $2.09. It's pulled back and tried to fill it a couple of times, and did partially fill it as the gap was larger earlier. It may try to fill that gap again before moving up. On the sell side - Some profit taking this morning IMO. Lot of shares were bought under $1.50 over the past 6 months. IMO, some of those folks are locking in 50% profits.
On the buy side - Great volume and accumulation in progress IMO. Need to burn thru the shares of the profit takers before moving up. I'm holding, as I expect we'll see the next leg-up and a breakout from the flag consolidation pattern sometime over the next 2 weeks.
GLTA.
|
|
|
|
Post by JHam on Jan 21, 2015 15:52:07 GMT
I just think we can expect to see this kind of trading until we get closer to the end of Q1.
|
|
|
|
Post by RLC on Jan 21, 2015 15:57:47 GMT
I just think we can expect to see this kind of trading until we get closer to the end of Q1. I was thinking the exact same. That's why I took some profits on the last run up over $2 (@ $2.12). I was tempted to make another sale early this morning but didn't. I think with about 2 months left until the guided data release, I'm just gonna sit tight. |
|
|
|
Post by jckrdu on Jan 21, 2015 21:44:04 GMT
Nice volume in the first 10-15 minutes of trading. Very small gap between $2.07 and $2.09. It's pulled back and tried to fill it a couple of times, and did partially fill it as the gap was larger earlier. It may try to fill that gap again before moving up. On the sell side - Some profit taking this morning IMO. Lot of shares were bought under $1.50 over the past 6 months. IMO, some of those folks are locking in 50% profits.
On the buy side - Great volume and accumulation in progress IMO. Need to burn thru the shares of the profit takers before moving up. I'm holding, as I expect we'll see the next leg-up and a breakout from the flag consolidation pattern sometime over the next 2 weeks.
GLTA.
Nice close today at $2.00 with another late day surge of volume.
Up 10% yesterday... gave back 3% today.
Good consolidation at a higher base on about twice the average volume... I'll take it.
|
|
|
|
Post by jckrdu on Jan 22, 2015 0:52:25 GMT
ATHX's strategy of focusing on commercializing in Japan makes sense. I expect more regenerative medicine companies to follow their lead. They have plans beyond stroke for the Japan market.
_________________________________
Nikkei Asian Review - Biotech flocking to Japan to sell regenerative medicine
TOKYO -- " Japan is attracting companies from around the world that are working to develop regenerative medicine treatments, thanks to a regulatory change that shortens approval times significantly. Based on new laws that took effect in November, regenerative medicine treatments can be approved in as little as two to three years in Japan, compared with the roughly seven years required previously. This is the speediest in the world. In Western markets, approval takes about seven years... The Japanese market for regenerative medicine, which stood at 9 billion yen ($74.1 million) in 2012, is projected to expand to 95 billion yen in 2020 and 1 trillion yen in 2030, according to the industry ministry. The government of Prime Minister Shinzo Abe has positioned regenerative medicine as a pillar of its growth strategy. By attracting foreign companies with high-level skills, Japanese industry could get a technological boost, too." Less
asia.nikkei.com/Tech-Science/Tech/Biotech-flocking-to-Japan-to-sell-regenerative-medicine
|
|
|
|
Post by Yelk on Jan 22, 2015 2:36:15 GMT
It is an exciting time for Biotech in Japan to be sure, now we just have to find the companies that will be successful there. Thanks for the post! Good read.
|
|
|
|
Post by jckrdu on Jan 22, 2015 12:20:56 GMT
|
|
|
|
Post by selluwud on Jan 22, 2015 12:53:11 GMT
"The grant is expected to provide up to approximately [Pounds]2.0 million in support over the course of the study, which will be conducted by Athersys Limited at leading clinical sites in the UK in conjunction with the Cell Therapy Catapult." 2 million pounds is 3+ million USD non-dilutive funds to conduct the trials. Nice. |
|
|
|
Post by Yelk on Jan 22, 2015 15:03:36 GMT
I really want to buy more at these levels... hmmm suprised so bearish today. -3.5%
|
|
|
|
Post by jckrdu on Jan 22, 2015 15:14:15 GMT
I really want to buy more at these levels... hmmm suprised so bearish today. -3.5% Accumulation in process. I don't think it stays below $2 much longer. I'm still expecting a breakout sometime over the next 1-2 weeks.
I added a little more today at $1.95.
GLTA.
|
|
|
|
Post by jckrdu on Jan 22, 2015 15:37:26 GMT
I really want to buy more at these levels... hmmm suprised so bearish today. -3.5% Yelk - Good luck with however you play it. While ATHX could certainly retrace, my reading of the tea leaves says its heading higher pretty soon for reasons stated in my prior posts. The only thing I'll add is to take a look at the 3 month chart: ATHX has been trading/consolidating in the $1.80 to $2.00 ish range for the past 3-4 weeks. Over the last week or so its started consolidating at the higher end of that range. To me, it looks like a breakout from this range is imminent.
Of course I could be wrong, so good luck.
IMO, next leg up will be to $2.15-ish. Once its breaks through that resistance there's some resistance at $2.30 and then $2.50 ish.
|
|
|
|
Post by Yelk on Jan 22, 2015 15:52:45 GMT
My thoughts are similar which is why haven't had much qualms on the big dips. The way I figure it the lowest it can possibly go before the news is 1.7x and the highest it can go on the run-up is really unknown especially if there is any positive news at all before. I can take the loss at 1.7x but I would never sleep if it really ran and I wasn't in Especially after all the research and energy imputed into this company. |
|
|
|
Post by dayanand33 on Jan 22, 2015 17:27:44 GMT
My thoughts are similar which is why haven't had much qualms on the big dips. The way I figure it the lowest it can possibly go before the news is 1.7x and the highest it can go on the run-up is really unknown especially if there is any positive news at all before. I can take the loss at 1.7x but I would never sleep if it really ran and I wasn't in Especially after all the research and energy imputed into this company. I also added a bit more. Any purchase under $2 seems safe. I am sure there is bound to be a lot of excitement around this stock because (a) these are phase II results of a stem cell sector stock and I bet a lot of people are following this sector, if not ATHX in particular. The rest of the public stem cell sector cos are at least a year behind completing the phase II. (b) the Japanese legislation will motivate many analysts to increase the valuation as we approach the results date. |
|
. Oh well the game we play. Interesting times ahead of us.
